– Del-Rio-Navarro B, Espinosa-Rosales FJ, Flenady V, Sienra-Monge JJL. Cochrane Review: Immunostimulants for preventing respiratory tract infections in children. Evid.-Based Child Health, Bd. 7, Nr. 2, S. 629–717:2012.
– Shah SA, Sander S, White M, Rinaldi M, Coleman CJ. Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infect Dis, Bd. 7, Nr. 7, S. 473–480:2007.
– Karsch-Völk M, Barrett B, Linde K. Echinacea for Preventing and Treating the Common Cold. JAMA, Bd. 313, Nr. 6, S. 618–619.2015.
– Autier P, Mullie P, Macacu A, Dragomir M, Boniol M, Coppens K. Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials. Lancet Diabetes Endo, Bd. 5, Nr. 12, S. 986–1004:2017.
Literatur
1 Linder JA. Comparative Effectiveness of Three Anxiolytics for Acute Respiratory Infections: Antibiotics, C-Reactive Protein Point-of-Care Testing, and Improved Communication. J Gen Intern Med. Bd. 30, Nr.4,S.387–9:2015.
2 Hofmann Y, et al. Behandlung der Streptokokken-Angina – Zeit für einen Paradigmenwechsel. EMH Media, Bd. 19, Nr. 2930, S. 481–8:2019.
3 Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev, Bd. 8, Art. CD001831:2012.
4 Venekamp RP, et al. Systemic corticosteroids for acute sinusitis. Cochrane Database Syst Rev, Bd. 3, Art. CD008115:2014.
5 Zalmanovici Trestioreanu A, Yaphe J. Intranasal steroids for acute sinusitis. Cochrane Database Syst Rev, Bd. 12, Art. CD005149:2013.
6 Hendley LO, Abbott RD, Beasley PP, Gwaltney JM. Effect of Inhalation of Hot Humidified Air on Experimental Rhinovirus Infection. JAMA. Bd. 271, Nr. 14, S. 1112–3:1994.
7 Forstall GJ, Macknin ML, Yen-Lieberman BR, VanderBrug Medendorp S. Effect of Inhaling Heated Vapor on Symptoms of the Common Cold. JAMA. Bd. 271, Nr. 14, S. 1109–111:1994.
8 Monto AS. The Common Cold: Cold Water on Hot News. JAMA. Bd. 271, Nr. 14, S. 1122–4:1994.
9 Singh M. Heated, humidified air for the common cold. Cochrane Database Syst Rev, Bd. 5, Art. CD001728:2011.
10 Francino MP. Antibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of Resistances. Front Microbiol, Bd. 6, Nr. 1543.2016.
11 Oldenburg CE, u.a. Gut Resistome After Oral Antibiotics in Preschool Children in Burkina Faso: A Randomized Controlled Trial. Clin Infect Dis. Art. ciz455:2019.
12 Heikkinen T, Järvinen A. The common cold. The Lancet, Bd. 361, Nr. 9351, S. 51–9: 2003.
13 Rovers MM, Balemans WA, Sanders EA, van der Ent CK, Zielhuis GA, Schilder AG. Persistence of upper respiratory tract infections in a cohort followes from childhood to adulthood. Family Practice, Bd. 23, Nr. 3, S. 286–90:2006.
14 Del-Rio-Navarro B, Espinosa-Rosales FJ, Flenady V, Sienra-Monge JJL. Cochrane Review: Immunostimulants for preventing respiratory tract infections in children. Evid.-Based Child Health, Bd. 7, Nr. 2, S. 629–717:2012.
15 Sullivan JE, Farrar HC. Clinical Report – Fever and Antipyretic Use in Children. Pediatrics, Bd. 127, Nr. 3, S. 580–7:2011.
16 Richardson M, Purssell E. Who’s afraid of fever? Arch Dis Child, Bd. 100, Nr. 9, S. 818–20:2015.
17 Graham NM, Burrell CJ, Douglas RM, Debelle P, Davies L. Adverse Effects of Aspirin, Acetaminophen, and Ibuprofen on Immune Function, Viral Shedding, and Clinical Status in Rhinovirus-Infected Volunteers. J Infect Dis, Bd. 162, Nr. 6, S. 1277–82:1990.
18 Brandts CH, Ndjavé M, Graninger W, Kremsner PG. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet. Bd. 350, Nr. 9079, S. 704–9:1997.
19 Prymula R, Siegrist C-A, Chlibek R, Zemlickova H, Vackova M, Smetana J, et al. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials. Lancet. Bd. 374, Nr. 9698, S. 1339–50:2009.
20 Bioforce. A. Vogel: Pflanzliches Arzneimittel Echinaforce
® Tabletten. Bioforce, 30-Aug-2018. [Online]. Verfügbar unter:
https://www.bioforce.ch/de/produkte/arzneimittel/echinaforce_tabletten.php?_ga=2.29882296.605880013.1553503140-1690005440.1548071265. [Zugegriffen: 25-März-2019].
21 Pleschka S, Stein M, Schoop R, Hudson JB. Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian Influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV). Virology Journal. Bd. 6, Nr. 197:2009.
22 Sharma M, Anderson SA, Schoop R, Hudson JB. Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract. Antiviral Research. Bd. 83, Nr. 2, S. 165–70:2009.
23 Jawad M, Schoop R, Suter A, Klein P, Eccles R. Safety and Efficacy Profile of Echinacea purpurea to Prevent Common Cold Episodes: A Randomized, Double-Blind, Placebo-Controlled Trial. Evid Based Complement Alternat Med. Bd. 2012, Nr. 841315:2012.
24 Manayi A, Vazirian M, und Saeidnia S. Echinacea purpurea: Pharmacology, phytochemistry and analysis methods. Pharmacogn Rev, Bd. 9, Nr. 17, S. 63–72:2015.
25 Barrett B, et al. Echinacea for Treating the Common Cold. Ann Intern Med. Bd. 153, Nr. 12, S. 769–77:2010.
26 Rauš K, Pleschka S, Klein P, Schoop R, Fisher P. Effect of an Echinacea-Based Hot Drink Versus Oseltamivir in Influenza Treatment: A Randomized, Double-Blind, Double-Dummy, Multicenter, Noninferiority Clinical Trial. Curr Ther Res Clin Exp. Bd. 77, S. 66–72:2015.
27 Karsch-Völk M, Barrett B, Linde K. Echinacea for Preventing and Treating the Common Cold. JAMA. Bd. 313, Nr. 6, S. 618–9:2015.
28 Shah SA, Sander S, White M, Rinaldi M, Coleman CJ. Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infect Dis. Bd. 7, Nr. 7, S. 473–80, Juli 2007.
29 Taylor JA, Weber W, Standish L, McGann M, Calabrese C. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. JAMA. Bd. 290, Nr. 21, S. 2824–30:2003.
30 Koordinationsstelle Forschung am Menschen. Wirksamkeit und Sicherheit von Echinacea Produkten bei Erkältungen. Kofam: Studienregister SNCTP, 13-Mai-2019. [Online]. Verfügbar unter:
https://www.kofam.ch/de/studienportal/studie/44496/. [Zugegriffen: 13-Mai-2019].
31 Ogal M, Klein P, Schoop R. Echinacea for the Prevention of Respiratory Tract Infections in Children 4–12 years: A Randomized, Blind and Controlled Study. Swiss Med Wkly. Bd. 148, Nr. Supplementum 228 “Joint Annual Meeting: Swiss Society of Paediatrics, Swiss Society of Paediatric Surgery and Swiss Society of Child and Adolescent Psychiatriy and Psychotherapy” (Lausanne, 24./25. Mai 2018), S. 6, Mai 2018. [Online]. Verfügbar unter:
https://smw.ch/ fileadmin/content/supplements/SMW_Suppl_228.pdf. [Zugegriffen: 19-August-2019].
32 Sangvai S, Chianese J, Morone N, Bogen DL, Voigt L, Shaikh N. Can an Herbal Preparation of Echinacea, Propolis, and Vitamin C Reduce Respiratory Illnesses in Children? Arch Pediatr Adolesc Med. Bd. 158, Nr. 3, S. 222–4:2004.
33 Schwabe Pharma AG. Pflanzenkraft statt Antibiotika. o.D. [Online]. Verfügbar unter:
https://www.umckaloabo.ch/de/umckaloabo/pflanzenkraft-statt-antibiotika/. [Zugegriffen: 22-Apr-2019].
34 Roth M, Fang L, Tamm M, Stolz D. Pelargonium sidoides radix extract EPs 7630 reduces rhinovirus infection through modulation of viral binding proteins on human bronchial epithelial cells. PLoS One. Bd. 14, Nr. 2, Art. e0210702:2019.
35 Michaelis M, Doerr HW, Cinatl Jr J. Investigation of the influence of EPs® 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses. Phytomedicine. Bd. 18, Nr. 5, S. 384–6:2011.
36 Timmer A, Günther J, Motschall E, Rücker G, Antes G, Kern WV. Pelargonium sidoides extract for treating acute respiratory tract infections. Cochrane Database Syst Rev, Bd. 10, Art. CD006323, Okt. 2013.
37 Günther J, Hinneburg I. Pelargonium bei Atemwegsinfekten. Pharmazeutische Zeitung, Berlin, 22-Feb-2016. [Online]. Verfügbar unter:
https://www.pharmazeutische-zeitung.de/ausgabe-082016/pelargonium-bei-atemwegsinfekten/. [Zugegriffen: 13-Mai-2019].
38 Tahan F, Yaman M. Can the Pelargonium sidoides root extract EPs® 7630 prevent asthma attacks during viral infections of the upper respiratory tract in children? Phytomedicine. Bd. 20, Nr. 2, S. 148–150:2013.
39 Stolz D, et al. Diagnosis, Prevention and Treatment of Stable COPD and Acute Exacerbations of COPD: The Swiss Recommendations 2018. Respiration. Bd. 96, Nr. 4, S. 382–98:2018.
40 Matthys H, Pliskevich DA, Bondarchuk O, Malek FA, Tribanek M, Kieser M. Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPD. Respir Med. Bd. 107, Nr. 5, S. 691–701:2013.
41 Matthys H, Funk P. Pelargonium sidoides preparation EPs 7630 in COPD: health-related quality-of-life and other patient-reported outcomes in adults receiving add-on therapy. Curr Med Res Opin. Bd. 34, Nr. 7, S. 1245–1251.2018.
42 Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status an ill health: a systematic review. Lancet Diabetes Endo. Bd. 2, Nr. 1, S. 76–89:2014.
43 Bundesamt für Gesundheit BAG. Vitamin-D-Mangel: Datenlage, Sicherheit und Empfehlungen für die Schweizer Bevölkerung. Bundesamt für Gesundheit, Bern, März 2012. [Online]. Verfügbar unter:
https://www.eek.admin.ch/dam/eek/de/dokumente/publikation-und-dokumentation/ausfuehrlicher-expertenbericht-vitamin-d-mangel.pdf.download.pdf/ Vitamin_D_Bericht.pdf [Zugegriffen: 19-August-2019].
44 Bischoff-Ferrari HA, et al. Empfehlungen der Eidgenössischen Ernährungskommission zur Vitamin-D-Zufuhr für die Schweizer Bevölkerung. Schweiz Med Forum. Bd. 12, Nr. 40, S. 775–778, Jan. 2012.
45 Coussens AK, et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. PNAS, Bd. 109, Nr. 38, S. 15449–15454. 2012.
46 Wu HX, Xiong XF, Zhu M, Wei J, Zhuo KQ, Cheng DY. Effects of vitamin D supplementation on the outcomes of patients with pulmonary tuberculosis: a systematic review and meta-analysis. BMC Pulm Med. Bd. 18, Nr. 1, S. 108:2018.
47 Manson JE, et al. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. N Engl J Med. Bd. 380, Nr. 1, S. 33–44:2019.
48 Autier P, Mullie P, Macacu A, Dragomir M, Boniol M, Coppens K. Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials. Lancet Diabetes Endo, Bd. 5, Nr. 12, S. 986–1004:2017.
49 Mandlik R, Chiplonkar S, Kajale N, Khadilkar V, Khadilkar A. Infection Status of Rural Schoolchildren and its Relationship with Vitamin D Concentrations. Indian J Pediatr. Bd. 86, Nr. 8, S. 675–680:2019.
50 Bose S, et al. Vitamin D Status Modifies the Response to Indoor Particulate Matter in Obese Urban Children with Asthma. J Allergy Clin Immunol Pract. Bd. 7, Nr. 6, S. 1815–1822:2019.
51 Vo P, et al. Vitamin D Status at the Time of Hospitalization for Bronchiolitis and Its Association with Disease Severity. J Pediatr. Bd. 203, S. 416–422:2018.
52 Martineau AR, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. Bd. 356, Art. i6583:2017.
53 Wang M, et al. Association between vitamin D status and asthma control: A meta-analysis of randomized trials. Respir Med, Bd. 150, S. 85–94:2019.
54 Vuichard Gysin D, Dao D, Gysin CM, Lytvyn L, Loeb MB. Effect of Vitamin D3 Supplementation on Respiratory Tract Infections in Healthy Individuals: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS One, Bd. 11, Nr. 9, Art. e0162996:2016.
55 Murdoch DR, et al. Effect of Vitamin D3 Supplementation on Upper Respiratory Tract Infections in Healthy Adults: The VIDARIS Randomized Controlled Trial. JAMA. Bd. 308, Nr. 13, S. 1333–1339:2012.
56 Lehouck A, et al. High Doses of Vitamin D to Reduce Exacerbations in Chronic Obstructive Pulmonary Disease: A Randomized Trial. Ann Intern Med. Bd. 156, Nr. 2, S. 105–114:2012.
57 Science M, Johnstone J, Roth DE, Guyatt G, Loeb MB. Zinc for the treatment of the common cold: a systematic review and meta-analysis of randomized controlled trials. CMAJ. Bd. 184, Nr. 10, S. E551–E561:2012.
58 Hemilä H, Petrus EJ, Fitzgerald JT, Prasad A. Zinc acetate lozenges for treating the common cold: an individual patient data meta-analysis. Br J Clin Pharmacol. Bd. 82, Nr. 5, S. 1393–1398:2016.
59 Hemilä H, Fitzgerald JT, Petrus EJ, Prasad A. Zinc Acetate Lozenges May Improve the Recovery Rate of Common Cold Patients: An Individual Patient Data Meta-Analysis. OFID, Bd. 4, Nr. 2, Art. ofx059:2017.
60 Eby III GA. Zinc for colds? Yes, but don’t swallow whole! J Fam Pract.Bd. 61, Nr. 1, Author Reply S. 9–10:2012.
61 Eby III GA. Zinc lozenges as cure for the common cold – a review and hypothesis. Med Hypothesis. Bd. 74, Nr. 3, S. 482–92:2010.
62 Schlatter C. Zink zur Behandlung und Prophylaxe von Erkältungen. Pharmaceutical Care Research Group, Universität Basel, i.m@il Offizin 22:2013.
63 Esposito S, Soto-Martinez ME, Feleszko W, Jones MH, Shen K-L, Schaad UB. Nonspecific immunomodulators for revurrent respiratory tract infections, wheezing and asthma in children: a systematic review of mechanistiv and clinical evidence. Curr Opin Allergy Clin Immunol. Bd. 18, Nr. 3, S. 198–209:2018.
64 Schaad UB. OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review. World J Pediatr. Bd. 6, Nr. 1, S. 5–12:2010.
65 Collet JP, Shapiro S, Ernst P, Renzi P, Ducruet T, Robinson A. Effects of an lmmunostimulating Aqent on Acute Exacerbations and Hospitalizations In Patients with Chronic Obstructive Pulmonary Disease: The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant. Am J Respir Crit Care Med. Bd. 156, Nr. 6, S. 1719–24:1997.
66 Solèr M, Mütterlein R, Cozma G. Double-Blind Study of OM-85 in Patients with Chronic Bronchitis or Mild Chronic Obstructive Pulmonary Disease. Respiration. Bd. 74, Nr. 1, S. 26–32:2006.
67 Hurst JR, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. Bd. 363, Nr. 12, S. 1128–1138, Sep. 2010.
68 Sprenkle MD, Niewoehner DE, MacDonald R, Rutks I, Wilt TJ. Clinical Efficacy of OM-85 BV in COPD and Chronic Bronchitis: A Systematic Review. COPD, Bd. 2, Nr. 1, S. 167–75:2005.
69 Pan L, Jiang XG, Guo J, Tian Y, Liu CT. Effects of OM-85 BV in Patients With Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. J Clin Pharmacol. Bd. 55, Nr. 10, S. 1086–1092, Okt. 2015.
70 European Medicines Agency. Bacterial lysate medicines for respiratory conditions to be used only for prevention of recurrent infections. European Medicines Agency: Science, Medicines, Health, 28-Juni-2019. [Online]. Verfügbar unter:
https://www.ema.europa.eu/en/news/bacterial-lysate-medicines-respiratory-conditions-be-used-only-prevention-recurrent-infections. [Zugegriffen: 15-Juli-2019].
71 Barrett B, et al. Meditation or exercise for Preventing Acute Respiratory Infection: A Randomized Controlled Trial. Ann Fam Med. Bd. 10, Nr. 4, S. 337–346:2012.
72 Kostka T, Berthouze SE, Lacour JR, Bonnefoy M. The symptomatology of upper respiratory tract infections and exercise in elderly people. Med Sci Sports Exerc, Bd. 32, Nr. 1, S. 46–51:2000.
73 Kostka T, Drygas W, Jegier A, Praczko K. Physical activity and upper respiratory tract infections. Int J Sports Med, Bd. 29, Nr. 2, S. 158–162:2008.
74 Kostka T, Praczko K. Interrelationship between physical activity, symptomatology of upper respiratory tract infections, and depression in elderly people. Gerontology, Bd. 53, Nr. 4, S. 187–193:2007.
75 Çiloğlu F. The effect of exercise on salivary IgA levels and the incidence of upper respiratory tract infections in postmenopausal women. Tr-ENT, Bd. 15, Nr. 5–6, S. 112–116:2005.
76 Matthews CE, Ockene IS, Freedson PS, Rosal MC, Merriam PA, Hebert JR. Moderate to vigorous physical activity and risk of upper-respiratory tract infection. Med Sci Sports Exerc. Bd. 34, Nr. 8, S. 1242–1248:2002.
77 Davison G, Kehaya C, Jones AW. Nutritional and Physical Activity Interventions to Improve Immunity. Am J Lifestyle Med. Bd. 10, Nr. 3, S. 152–169:2016.
78 Obasi CN, et al. Advantage of meditation over exercise in reducing cold and flu illness is related to improved function and quality of life. Influenza Other Respir Viruses. Bd. 7, Nr. 6, S. 938–944:2013.
79 Nieman DC, Henson DA, Austin MD, Sha W. Upper respiratory tract infection is reduced in physically fit and active adults. Br J Sports Med. Bd. 45, Nr. 12, S. 987–992:2011.
80 Chubak J, et al. Moderate-intensity exercise reduces the incidence of colds among postmenopausal women. Am J Med. Bd. 119, Nr. 11, S. 937–942:2006.
81 Nieman DC, et al. Immune response to exercise training and/or energy restriction in obese women. Med Sci Sports Exerc. Bd. 30, Nr. 5, S. 679–686:1998.
82 Weidner T, Schurr T. Effect of exercise on upper respiratory tract infection in sedentary subjects. BR J Sports Med. Bd. 37, Nr. 4, S. 304–306:2003.
83 Fondell E, et al. Physical Activity, Stress, and Self-Reported Upper Respiratory Tract Infection. Med Sci Sports Exerc. Bd. 43, Nr. 2, S. 272–279, Feb. 2011.
84 Spence L, et al. Incidence, Etiology, and Symptomatology of Upper Respiratory Illness in Elite Athletes. Med Sci Sports Exerc. Bd. 39, Nr. 4, S. 577–586:2007.
85 Moreira A, Delgado L, Moreira P, Haahtela T. Does exercise increase the risk of upper respiratory tract infections? Br Med Bull. Bd. 90, Nr. 1, S. 111–131:2009.
86 Grande AJ, Keogh J, Hoffmann TC, Beller EM, Del Mar CB. Exercise versus no exercise for the occurrence, severity and duration of acute respiratory infections (Review). Cochrane Database Syst Rev, Bd. 6, Art. CD010596:2015.
87 Cohen S, Doyle WJ, Alper CM, Janicki-Deverts D, Turner RB. Sleep Habits and Susceptibility to the Common Cold. Arch Intern Med. Bd. 169, Nr. 1, S. 62–67:2009.
88 Satomura K, et al. Prevention of Upper Respiratory Tract Infections by Gargling: A Randomized Trial. Am J Prev Med. Bd. 29, Nr. 4, S. 302–307:2005.
89 Goodall EC, et al. Vitamin D3 and gargling for the prevention of upper respiratory tract infections: a randomized controlled trial. BMC Infect Dis. Bd. 14, Nr. 1, S. 273:2014.
90 Jefferson T, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review. BMJ. Bd. 339, Art. b3675:2009.
91 Turner RB, Fuls JL, Rodgers ND, Goldfarb HB, Lockhart LK, Aust LB. A Randomized Trial of the Efficacy of Hand Disinfection for Prevention of Rhinovirus Infection. Clin Infect Dis. Bd. 54, Nr. 10, S. 1422–1426:2012.
92 Šlapak I, Skoupá J, Strnad P, Horník P. Efficacy of Isotonic Nasal Wash (Seawater) in the Treatment and Prevention of Rhinitis in Children. Arch Otolaryngol Head Neck Surg. Bd. 134, Nr. 1, S. 67–74:2008.
93 King D, Mitchell B, Williams CP, Spurling GKP. Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database Syst Rev, Bd. 4, Art. CD006821:2015.
94 Pynnonen MA, Mukerji SS, Kim M, Adams ME, Terrell JE. Nasal Saline for Chronic Sinonasal Symptoms: A Randomized Controlled Trial. Arch Otolaryngol Head Neck Surg. Bd. 133, Nr. 11, S. 1115–1120:2007.
95 Ramalingam S, Graham C, Dove J, Morrice L, Sheikh A. A pilot, open labelled, randomised controlled trial of hypertonic saline nasal irrigation and gargling for the common cold. Sci Rep. Bd. 9, Nr. 1, S. 1015:2019.
96 Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. Bd. 1, Art. CD000980:2013.
97 Paul IM, Beiler JS, King TS, Clapp ER, Vallati J, Berlin Jr. CM. Vapor Rub, Petrolatum, and No Treatment for Children With Nocturnal Cough and Cold Symptoms. Pediatrics. Bd. 126, Nr. 6, S. 1092–1099:2010.
98 Jund R, Mondigler M, Steindl H, Stammer H, Stierna P, Bachert C. Clinical efficacy of a dry extract of five herbal drugs in acute viral rhinosinusitis. Rhinology. Bd. 50, Nr. 4, S. 417–426:2012.
99 Jund R, Mondigler M, Stammer H, Stierna P, Bachert C. Herbal drug BNO 1016 is safe and effective in the treatment of acute viral rhinosinusitis. Acta Otolaryngol. Bd. 135, Nr. 1, S. 42–50:2015.
100 Grünwald J, Graubaum HJ, Busch R. Efficacy and tolerability of a fixed combination of thyme and primrose root in patients with acute bronchitis: A double-blind, randomized, placebo-controlled clinical trial. Drug Res. Bd. 55, Nr. 11, S. 669–676:2005.
101 Kemmerich B, Eberhardt R, Stammer H. Efficacy and tolerability of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bronchitis with productive cough: A prospective, double-blind, placebo-controlled clinical trial. Drug Res. Bd. 56, Nr. 9, S. 652–660:2006.
102 Gillisen A, Wittig Th, Ehmen M, Krezdom HG, de Mey C. A multi-centre, randomised, double-blind, placebo-controlled clinical trial on the efficacy and tolerability of GeloMyrtol® forte in acute bronchitis. Drug Res. Bd. 63, Nr. 1, S. 19–27:2013.
103 Bruhn C. Die pflanzliche Lösung: Saponine und ätherische Öle bei Erkältungshusten und akuter Bronchitis. DAZ. Stuttgart. Nr. 36, S. 40, 07-Sep-2017.
104 Paul IM, Beiler JS, McMonagle A, Shaffer ML, Duda L, Berlin Jr. CM, Effect of Honey, Dextromethorphan, and No Treatment on Nocturnal Cough and Sleep Quality for Coughing Children and Their Parents. Arch Pediatr Adolesc Med. Bd. 161, Nr. 12, S. 1140–1146:2007.
105 Goldman RD. Honey for treatment of cough in children. Can Fam Physician. Bd. 60, Nr. 12, S. 1107–1110:2014.
106 Josling P. Preventing the Common Cold With a Garlic Supplement: A Double-Blind, Placebo- Controlled Survey. Adv Therapy. Bd. 18, Nr. 4, S. 189–193:2001.